Babos Cristian I, Leucuta Daniel C, Dumitrascu Dan L
Second Medical Department, Iuliu Hatieganu University of Medicine and Pharmacy, Cluj-Napoca, ROU.
Medical Department, Prof. Dr. Octavian Fodor Regional Institute of Gastroenterology and Hepatology, Cluj-Napoca, ROU.
Cureus. 2024 Aug 30;16(8):e68226. doi: 10.7759/cureus.68226. eCollection 2024 Aug.
Mind-body therapies have been found to be effective in a variety of pathologies. The purpose of this study was to evaluate the efficacy of meditation-based therapies in relieving the symptoms severity, quality of life, stress and other associated mood conditions, in individuals with chronic neuropathy of various etiologies. A systematic review of randomized controlled trials, involving adult patients with persistent peripheral neuropathy, was performed. Seven article databases were searched. A meta-analysis was conducted to assess the benefits of meditation-based therapy on symptomatology, quality of life, anxiety, depression, perceived stress, sleep quality and mindfulness score. Ten of the 1133 reviewed papers were selected for quantitative review. The meditation group had a lower standardized mean difference (SMD) score (-0.47 (95% CI: -0.97 to 0.02), p=0.062) for neuropathic pain severity score; lower anxiety scores (-2.5 (95% CI: -3.68 to -1.32), p=<0.001); lower depression scores (-1.53 (95% CI: -2.12 to -0.93), p=<0.001); lower perceived stress (-1.06 (95% CI: -3.15 to 1.04), p=0.323); higher quality of life scores (2.19 (95% CI: -0.65 to 5.03), p=0.13); lower sleep quality scores (-1.27 (95% CI: -4.22 to 1.67), p=0.397); higher mindfulness scores (6.71 (95% CI: 4.09 to 9.33), p=<0.001); and lower pain severity at 1 to 1.5 follow up (-1.75 (95% CI: -2.98 to -0.51), p=0.006). Some of the results were characterized by a substantial, statistically significant heterogeneity. Nevertheless, a major part of the results pointed in the same direction, improving symptomatology with meditation-based therapy. The studies had a risk of bias mostly regarding the measurement of the outcome, randomization process and selection of the reported result. The current study discovered that the meditation group had significantly lower pain (at 1 to 1.5 months follow-up) anxiety, and depression scores and higher mindfulness scores at the end of the interventions.
身心疗法已被发现在多种病症中有效。本研究的目的是评估基于冥想的疗法对各种病因的慢性神经病变个体缓解症状严重程度、生活质量、压力及其他相关情绪状况的疗效。对涉及持续性周围神经病变成年患者的随机对照试验进行了系统评价。检索了七个文章数据库。进行了一项荟萃分析,以评估基于冥想的疗法在症状学、生活质量、焦虑、抑郁、感知压力、睡眠质量和正念评分方面的益处。在1133篇综述论文中,有10篇被选作定量综述。冥想组在神经病理性疼痛严重程度评分方面的标准化平均差(SMD)得分较低(-0.47(95%置信区间:-0.97至0.02),p = 0.062);焦虑得分较低(-2.5(95%置信区间:-3.68至-1.32),p < 0.001);抑郁得分较低(-1.53(95%置信区间:-2.12至-0.93),p < 0.001);感知压力较低(-1.06(95%置信区间:-3.15至1.04),p = 0.323);生活质量得分较高(2.19(95%置信区间:-0.65至5.03),p = 0.13);睡眠质量得分较低(-1.27(95%置信区间:-4.22至1.67),p = 0.397);正念得分较高(6.71(95%置信区间:4.09至9.33),p < 0.001);在1至1.5个月的随访中疼痛严重程度较低(-1.75(95%置信区间:-2.98至-0.51),p = 0.006)。部分结果存在显著的统计学异质性。然而,大部分结果指向同一方向,即基于冥想的疗法可改善症状。这些研究大多在结果测量、随机化过程和报告结果的选择方面存在偏倚风险。当前研究发现,冥想组在干预结束时疼痛(在1至1.5个月随访时)、焦虑和抑郁得分显著较低,正念得分较高。